Literature DB >> 17509799

Production of extracellular proteolytic activity by Histoplasma capsulatum grown in Histoplasma-macrophage medium is limited to restriction fragment length polymorphism class 1 isolates.

Robert Zarnowski1, Patricia A Connolly, L Joseph Wheat, Jon P Woods.   

Abstract

Extracellular proteolytic activity was studied for 28 strains of Histoplasma capsulatum var. capsulatum and 2 strains of H. capsulatum var. duboisii. Secreted protease activity assessed by skim milk agarose clearance was limited solely to H. capsulatum var. capsulatum restriction fragment length polymorphism (RFLP) class 1 strains. There was a difference in proteolytic activity levels among class 1 strains. Extracellular proteolytic activity was further determined during growth of those strains in liquid medium using azodye-impregnated protein substrates. In general, the highest activities were measured when azocollagen was used, whereas azocasein and azoalbumin were cleaved less efficiently. The activity was inhibited by phenylmethylsulfonyl fluoride, 4-(2-aminoethyl) benzenesulfonyl fluoride, antipain, and chymostatin, indicating, thereby, the presence of chymotrypsin-like serine proteases. Chromatographic analyses as well as variable substrate use at different culture times revealed production of at least 2 different enzyme pools of the same serine-like protease family. Our results demonstrate a distinctive ability of RFLP class 1 isolates to produce and secrete serine proteinase-type activity. This peculiarity may be relevant to the biology and pathogenesis of this particular clade of H. capsulatum isolates. Overall, the feature of extracellular proteolytic activity production enables a convenient and unequivocal identification of RFLP class 1 isolates and, thereby, can be used in H. capsulatum strain differentiation and typing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509799      PMCID: PMC2093958          DOI: 10.1016/j.diagmicrobio.2007.03.020

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  44 in total

Review 1.  Current diagnosis of histoplasmosis.

Authors:  L Joseph Wheat
Journal:  Trends Microbiol       Date:  2003-10       Impact factor: 17.079

2.  Histoplasmosis after multiple trauma.

Authors:  M M Stone; L M Frenkel; D H Howard
Journal:  Pediatr Infect Dis J       Date:  1990-10       Impact factor: 2.129

3.  Extracellular proteinase activity of Cryptococcus neoformans.

Authors:  L C Chen; E S Blank; A Casadevall
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

4.  Assaying proteinases with azocoll.

Authors:  R Chavira; T J Burnett; J H Hageman
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

5.  Influence of culture medium pH and proteinase inhibitors on extracellular proteinase activity and cell growth of Sporothrix schenckii.

Authors:  R Tsuboi; T Sanada; H Ogawa
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

6.  Classification of Histoplasma capsulatum isolates by restriction fragment polymorphisms.

Authors:  R D Vincent; R Goewert; W E Goldman; G S Kobayashi; A M Lambowitz; G Medoff
Journal:  J Bacteriol       Date:  1986-03       Impact factor: 3.490

7.  Use of mitochondrial and ribosomal DNA polymorphisms to classify clinical and soil isolates of Histoplasma capsulatum.

Authors:  E D Spitzer; B A Lasker; S J Travis; G S Kobayashi; G Medoff
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

8.  Cloning and disruption of the gene encoding an extracellular metalloprotease of Aspergillus fumigatus.

Authors:  K Jaton-Ogay; S Paris; M Huerre; M Quadroni; R Falchetto; G Togni; J P Latgé; M Monod
Journal:  Mol Microbiol       Date:  1994-12       Impact factor: 3.501

9.  Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores.

Authors:  P L Worsham; W E Goldman
Journal:  J Med Vet Mycol       Date:  1988-06

Review 10.  Gastrointestinal histoplasmosis in the acquired immunodeficiency syndrome: report of 18 cases and literature review.

Authors:  Maha Assi; David S McKinsey; Michael R Driks; Mary C O'Connor; Maurizio Bonacini; Bruce Graham; Farrin Manian
Journal:  Diagn Microbiol Infect Dis       Date:  2006-03-20       Impact factor: 2.803

View more
  9 in total

1.  Investigation of the efficacy of micafungin in the treatment of histoplasmosis using two North American strains of Histoplasma capsulatum.

Authors:  Chadi A Hage; Patricia Connolly; Daniel Horan; Michelle Durkin; Melinda Smedema; Robert Zarnowski; Patricia Smith; L Joseph Wheat
Journal:  Antimicrob Agents Chemother       Date:  2011-06-13       Impact factor: 5.191

Review 2.  Histoplasma mechanisms of pathogenesis--one portfolio doesn't fit all.

Authors:  Jessica A Edwards; Chad A Rappleye
Journal:  FEMS Microbiol Lett       Date:  2011-08-09       Impact factor: 2.742

3.  Secreted dipeptidyl peptidase IV activity in the dimorphic fungal pathogen Histoplasma capsulatum.

Authors:  Kendal G Cooper; Jon P Woods
Journal:  Infect Immun       Date:  2009-04-06       Impact factor: 3.441

4.  Serine protease inhibitor attenuates ovalbumin induced inflammation in mouse model of allergic airway disease.

Authors:  Sanjay Saw; Sagar Laxman Kale; Naveen Arora
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

5.  Definition of the extracellular proteome of pathogenic-phase Histoplasma capsulatum.

Authors:  Eric D Holbrook; Jessica A Edwards; Brian H Youseff; Chad A Rappleye
Journal:  J Proteome Res       Date:  2011-02-25       Impact factor: 4.466

6.  Genome Sequences Reveal Cryptic Speciation in the Human Pathogen Histoplasma capsulatum.

Authors:  Victoria E Sepúlveda; Roberto Márquez; David A Turissini; William E Goldman; Daniel R Matute
Journal:  mBio       Date:  2017-12-05       Impact factor: 7.867

7.  Histoplasma capsulatum encodes a dipeptidyl peptidase active against the mammalian immunoregulatory peptide, substance P.

Authors:  Kendal G Cooper; Robert Zarnowski; Jon P Woods
Journal:  PLoS One       Date:  2009-04-22       Impact factor: 3.240

8.  Novel entries in a fungal biofilm matrix encyclopedia.

Authors:  Robert Zarnowski; William M Westler; Ghislain Ade Lacmbouh; Jane M Marita; Jameson R Bothe; Jörg Bernhardt; Anissa Lounes-Hadj Sahraoui; Joël Fontaine; Hiram Sanchez; Ronald D Hatfield; James M Ntambi; Jeniel E Nett; Aaron P Mitchell; David R Andes
Journal:  MBio       Date:  2014-08-05       Impact factor: 7.867

9.  Metabolism of Gluconeogenic Substrates by an Intracellular Fungal Pathogen Circumvents Nutritional Limitations within Macrophages.

Authors:  Qian Shen; Stephanie C Ray; Heather M Evans; George S Deepe; Chad A Rappleye
Journal:  mBio       Date:  2020-04-07       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.